Uploaded December 2025 | Updated September 2026, 3 weeks ago

---

Dr Caroline Barelle, Founder and CEO of Elasmogen Ltd, talks through how BBSRC Follow-on Funding awarded to the University of Aberdeen provided the crucial bridge between their shark antibody discovery and the development needed to create a commercially ready platform for spin-out.

________
We are UK Research and Innovation, the UK's largest public funder of research and innovation. If you're a UK tax payer, your contributions help fund the work we showcase on our channel. And if you liked this video, follow us on these channels:

Medium: medium.com/@UKRI

Instagram: instagram.com/weareukri

Facebook: facebook.com/weareUKRI

YouTube:  youtube.com/c/UKResearchandInnovation

Or sign up for our weekly newsletter public.govdelivery.com/accounts/UKRI/subscriber/new?topic_id=UKRI_newsletter